PCSK9 Inhibitors Show Value for Patients and the US Health Care System.

MLA

Wei-Han Cheng, et al. “PCSK9 Inhibitors Show Value for Patients and the US Health Care System.” Value in Health, vol. 20, no. 10, Dec. 2017, pp. 1270–78. EBSCOhost, https://doi.org/10.1016/j.jval.2017.05.014.

APA

Wei-Han Cheng, Gaudette, É., Goldman, D. P., & Cheng, W.-H. (2017). PCSK9 Inhibitors Show Value for Patients and the US Health Care System. Value in Health, 20(10), 1270–1278. https://doi.org/10.1016/j.jval.2017.05.014

Chicago

Wei-Han Cheng, Étienne Gaudette, Dana P. Goldman, and Wei-Han Cheng. 2017. “PCSK9 Inhibitors Show Value for Patients and the US Health Care System.” Value in Health 20 (10): 1270–78. doi:10.1016/j.jval.2017.05.014.